CLOs on the Move

Biometrica Systems Inc

www.biometrica.com

 
Biometrica Systems Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Las Vegas, NV. To find more information about Biometrica Systems Inc, please visit www.biometrica.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.biometrica.com
  • 750 E Warm Springs Rd Ste 240
    Las Vegas, NV USA 89119-4383
  • Phone: 702.870.6949

Executives

Name Title Contact Details

Similar Companies

SameSky Health

SameSky Health is a developer of a patient engagement platform intended to connect payers, providers, and health systems with multi-cultural Medicare patient populations. The company`s platform addresses the needs of clients with multi-cultural populations through web and application-based integrated services including multi-channel messaging, care navigation, and data insights and consultancy. It was formerly known as ConsejoSano and changed it`s name to SameSky Health. The company was founded in 2017 and is based in North Hollywood, California.

BSD Medical Corporation

BSD Medical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Salt Lake City, UT. To find more information about BSD Medical Corporation, please visit www.bsdmc.com

Cianna Medical Inc

Cianna Medical Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Aliso Viejo, CA. To find more information about Cianna Medical Inc, please visit www.ciannamedical.com

AdvanSource Biomaterials Corporation

AdvanSource Biomaterials Corporation is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.